1171 |
Examining Infarct Sizes In Female Sprague Dawley Rats In Response To A Delayed Post-Stroke Pharmacological Treatment In Combination With Physical RehabilitationDharmadhikari, Sayali Ravindra 22 August 2016 (has links)
No description available.
|
1172 |
Examination Of A Post-Stroke Drug Treatment For Its Effect On Blood Brain Barrier Permeability, And Gene Expression Changes In The Peri-Infarct RegionPatel, Ankita Anil 29 August 2016 (has links)
No description available.
|
1173 |
Enhanced Neurogenesis In Subventricular Zone Of Rats That Voluntarily Ingest Fluoxetine And Simavastatin Combination TreatmentFlannery, Tiffany L. 02 May 2017 (has links)
No description available.
|
1174 |
Natural Vitamin E, α-Tocotrienol, as a NeuroprotectantPark, Han-A 17 December 2010 (has links)
No description available.
|
1175 |
MICRO/NANOSCALE ENGINEERING OF THE CELL MICROENVIRONMENTGallego-Perez, Daniel 28 July 2011 (has links)
No description available.
|
1176 |
Anatomy and Pharmacology of Dopamine Transporter-Mediated Reward and Locomotor Responses to PsychostimulantsO'Neill, Brian 18 December 2012 (has links)
No description available.
|
1177 |
The Immunoregulatory and Neuroprotective roles of Dimethyl Fumarate in Multiples SclerosisPeng, Haiyan 20 December 2012 (has links)
No description available.
|
1178 |
Anatomical Characterization and Cellular Physiology of Rat Aortic Body ChemoreceptorsPiskuric, Nikol A. 10 1900 (has links)
<p>Aortic bodies (ABs) are putative peripheral arterial chemoreceptors located near the aortic arch. They are hypothesized to contribute to O<sub>2</sub> homeostasis by sensing arterial O<sub>2</sub> content and initiating cardiovascular reflexes during hypoxia; however, information on their cellular physiology is lacking. The primary goal of this thesis was to elucidate chemosensory mechanisms among mammalian (rat) AB cells, located specifically at the bifurcation of the left vagus nerve and recurrent laryngeal nerve (RLN), where they are found in association with a group of local neurons (>30). In vagus nerve-RLN whole-mounts, AB chemoreceptor (type I) cells were immunoreactive against the vesicular acetylcholine (ACh) transporter, and were surrounded by nerve terminals immunopositive for purinergic P2X2 and P2X3 receptor subunits, suggesting that ACh and ATP may act as neurotransmitters as in the related carotid body. In a novel dissociated AB culture model, subsets of type I cells exhibited elevated intracellular Ca<sup>2+</sup> responses to hypoxia, isohydric hypercapnia, isocapnic acidosis, and acidic hypercapnia, demonstrating their direct chemosensitivity for the first time. Interestingly, surviving local neurons also responded to these chemostimuli, suggesting that they are sensory. Patch clamp electrophysiological and Ca<sup>2+</sup> imaging studies revealed functional heteromeric P2X2/3 and nicotinic ACh receptors on local neurons, consistent with ACh and/or ATP mediating chemotransmission between receptor cells and local neurons. These neurons were also found to be interconnected by electrical synapses. Finally, the short-term survival of red blood cells (RBCs) in AB cultures, along with the finding that blood-borne factors (e.g. ATP released from RBCs) may have access to AB nerve terminals <em>in situ</em>, implicates RBCs as O<sub>2</sub>-sensors in AB function. Altogether, these results suggest an important role for purinergic P2X2/3 receptors on local neurons/nerve terminals and ATP release from type I cells and RBCs, in the unique ability of ABs to sense and process information about blood O<sub>2</sub> content.</p> / Doctor of Philosophy (PhD)
|
1179 |
EFFECTS OF VALPROIC ACID ON EXPRESSION OF THE MELATONIN RECEPTORS MT1 AND MT2, AND THE NEUROTROPHIC FACTORS BDNF AND GDNF IN VIVOSathiyapalan, Arani 04 1900 (has links)
<p>Valproic acid (VPA) is clinically utilized as an anti-convulsant and mood stabilizer, though its mechanism of action has not been fully elucidated.<strong> </strong>Evidence suggests an interaction between VPA and the melatonergic system as VPA up-regulated the melatonin MT<sub>1</sub> receptor subtype in rat C6 glioma cells. To determine if the observed effects can translate to an <em>in vivo </em>model, we investigated the effects of chronic VPA administration in a rat model on the expression of MT<sub>1</sub> and MT<sub>2</sub> receptors in the hippocampus. We also investigated the effect of chronic VPA treatment on the expression of the neurotrophic factors BDNF and GDNF in the rat hippocampus and striatum.</p> <p>(1) Animals were separated into two groups with the experimental group receiving VPA (4 mg/mL) for 17 days, and the control receiving vehicle. The hippocampus was dissected and MT<sub>1</sub>, MT<sub>2</sub>, BDNF and GDNF mRNA were analyzed with RT-PCR. (2) Animals were separated into three groups with the first group receiving VPA (4 mg/mL), the second receiving VPA (3 mg/mL) for 16 days, and the control receiving vehicle. MT<sub>2</sub> mRNA in the hippocampal subregions were analyzed with in situ hybridization.</p> <p>VPA induced the expression of MT<sub>1</sub> and MT<sub>2</sub> mRNA in the hippocampus in the experimental group compared to the control group. VPA also increased MT<sub>2</sub> mRNA expression in the subregions of the hippocampus. Additionally, BDNF and GDNF mRNA expression were increased in the VPA treatment group.</p> <p>These findings raise the interesting question of whether the diverse clinical effects of VPA involve an interaction with the melatonergic system.</p> / Master of Science (MSc)
|
1180 |
ERBB4 KINASE DYNAMICALLY REGULATES HIPPOCAMPAL-PREFRONTAL SYNCHRONY AND HIPPOCAMPAL SHARP WAVE RIPPLES IMPORTANT FOR ATTENTION AND MEMORYRobinson, Heath Larsson 23 May 2022 (has links)
No description available.
|
Page generated in 0.0465 seconds